Skip to main content

Table 4 Costs of healthcare services

From: Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective

Item

Unit costs

Drug

  Ranibizumab (unit costs)

¥3,950.00

Medical treatment services

  Laser

¥605.00

  Administration of ranibizumab

¥776.00

  Follow-up visit

¥664.00

Annual indirect medical costs and non-medical service

  BCVA 36–55

¥30,849.00

  BCVA <  = 35

¥47,396.00